ArticleMolecular therapy. Advances2026

Safety and HBsAg reduction with a lentiviral vaccine J-51 in chronic hepatitis B: An investigator-initiated pilot trial.

Jieyu Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.